Doxorubicin demonstrated greater efficacy, with stronger tumour inhibition and increased apoptosis compared with TP (Ki67, TP vs. doxorubicin, p < .001; Figure S10E; TUNEL, TP vs. doxorubicin, p = .009; Figure S10F). The gene discussed is MKI67; the disease is neoplasm.